期刊文献+

LC-MS/MS同时测定曲美布汀和活性代谢物在Beagle犬体内的血药浓度及其药代动力学研究 被引量:3

LC-MS/MS simultaneous determination and pharmacokinetics of trimebutine and it's metabolite in Beagle plasma
原文传递
导出
摘要 目的:建立灵敏稳定的HPLC-MS/MS方法,用于测定Beagle犬血浆中的曲美布汀(TM)及N-去甲基曲美布汀(N-TM)含量,并研究曲美布汀片剂在健康Beagle犬体内的药代动力学。方法:样品处理采用液液萃取方法,选择西布曲明(IS)为内标。进行HPLC-MS/MS分析,采用ESI源,MRM离子检测模式,TM、N-TM和IS的检测离子对分别为m/z 388.2→343.2,m/z 374.2→195.2,m/z 280.3→125.1。单剂量给药300 mg后,测定犬血浆中TM及N-TM的浓度,并计算药代动力学参数。结果:血浆中TM及N-TM检测的线性范围分别为1~500 ng.mL-1(r=0.9959),0.2~100 ng.mL-1(r=0.9951),萃取回收率均高于85%,日内、日间RSD均小于10%。犬血浆中TM及N-TM Cmax分别为(192±32.1)ng.mL-1和(47.1±22.6)ng.mL-1,Tmax均为(0.667±0.258)h和(1.08±0.492)h,T1/2分别为为(10.8±4.27)h和(7.06±2.53)h。结论:该方法可简便、高效地测定犬血浆中TM及N-TM浓度,并应用于药代动力学研究。 Objective:To develop an LC-MS/MS method for the simultaneous determination of trimebutine(TM) and N-monodemethyltrimebutine(N-TM) concentration in dog plasma to study the pharmacokinetics of TM maleate in healthy Beagles.Method:The analytes were extracted from plasma samples by liquid-liquid extraction and sibutramine was selected to be the internal standard.Detection was carried out on a triple quadrupole tandem mass spectrometer in multiple reactions monitoring(MRM) mode using positive electrospray ionization(ESI).The ion combination of m/z 388.2→m/z 343.2,m/z 374.2→m/z 195.2,m/z 280.3→m/z 125.1 was used to qualify TM,N-TM and the internal standard,respectively.After a single oral dose of 300 mg TM,the concentrations of TM and N-TM were detected and the pharmacokinetic parameters were calculated by DAS 2.0.Result:The calibration curve was in good linearity over the range of 1-500 ng·mL-1(r=0.9959) for TM and 0.2-100 ng·mL-1(r=0.9951) for N-TM.The intra-day and inter-day precisions(RSD) were lower than 10% and the extraction recovery was higher than 85% for both determined compounds.The main pharmacokinetic parameters of Cmax,Tmax and T1/2 were(192±32.1)ng·mL-1,(0.667±0.258)h,(10.8±4.27)h for trimebutine(47.1±22.6)ng·mL-1,(1.08±0.492)h,7.06±2.53 h for N-TM,respectively.Conclusion:The method is shown to be simple,accurate,sensitive and specific for the simultaneous determination of TM and N-TM in Beagles plasma and can be used for the pharmacokinetic study.
出处 《药物分析杂志》 CAS CSCD 北大核心 2012年第8期1351-1356,共6页 Chinese Journal of Pharmaceutical Analysis
关键词 曲美布汀(TM) N-去甲基曲美布汀(N-TM) LC-MS/MS 药代动力学 比格犬血浆样品检测 trimebutine(TM) N-monodemethyltrimebutine(N-TM) LC-MS/MS pharmacokinetics Beagle plasma samples detection
  • 相关文献

参考文献12

  • 1Delvaux M,Wingate D.Trimebutine:mechanism of action,effects on gastrointestinal function and clinical results.J Int Med Res,1997,25(5):225.
  • 2Hauschke D,Steinijans VW,Diletti E.A distribution-free procedure for the statistical analysis of bioequivalence studies.Int J Clin Pharmacol Ther Toxicol,1990,28(2):72.
  • 3Poynard T,Naveau S,Mory B,et al.Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome.Aliment Pharmacol Ther,1994,8(5):499.
  • 4Fioramonti J,Bueno L.Centrally acting agents and visceral sensitivity.Gut,2002,51:i91.
  • 5Kountouras J,Chatzopoulos D,Zavos C,et al.Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome.Hepatogastroenterology,2002,49(43):193.
  • 6Roman FJ,Lanet S,Hamon J,et al.Pharmacological properties of trimebutine and N-monodesmethyl trimebutine.J Pharmacol Exp Ther,1999,289(3):1391.
  • 7Wang H,Zhou H,Horimoto S,et al.Quantitative determination of trimebutine maleate and its three metabolites in human plasma by liquid chromatography-tandem mass spectrometry.J Chromatogr B Anal Technol Biomed Life Sci,2002,779(2):173.
  • 8姜红,丁黎,杨劲,黄鑫,刘广余,张正行.曲美布汀分散片健康人体内的药代动力学及生物等效性研究[J].药学学报,2004,39(3):208-211. 被引量:4
  • 9刘湘,符健,伍海涛.马来酸曲美布汀干混悬剂的生物等效性研究[J].中南药学,2006,4(1):14-16. 被引量:5
  • 10何飞,涂家生,殷琳琳,胡瑜兰,张钧寿.马来酸曲美布汀缓释片的家犬药动学研究[J].中国药科大学学报,2001,32(2):122-126. 被引量:8

二级参考文献10

共引文献10

同被引文献107

  • 1王海龙,李劲彤,李敬来,蒙根,魏开华,阮金秀.稳定同位素标记结合离子阱质谱鉴别大鼠尿中胍丁胺及其乙酰化代谢产物[J].药物分析杂志,2005,25(2):131-136. 被引量:3
  • 2张伯礼,王永炎.方剂关键科学问题的基础研究——以组分配伍研制现代中药[J].中国天然药物,2005,3(5):258-261. 被引量:168
  • 3陈勇,沈少林,陈怀侠,韩凤梅.HPLC-ESI-ITMS^n法鉴定麻黄碱及其大鼠体内主要代谢产物[J].药学学报,2005,40(9):838-841. 被引量:27
  • 4Pelkonen O. Prediction of drug metabolism and interactions on the basis of in vitro investigations[ J ]. Basic Clin Pharmacol Tox- icol,2005,96 (3) :167.
  • 5Eddershaw PJ, Beresford AP, Bayliss MK. ADME/PK as part of a rational approach to drug discovery [ J ]. Drug Discov Today, 2000,5(9) :409.
  • 6Roberts SA. Drug metabolism and pharmacokinetics in drug dis- covery[ J]. Curr Opin Drug Discov Dev,2003,6( 1 ) :66.
  • 7Coocke S, Ahr H, Blaauboer B J, et al. Metabolism: a bottleneck in vitro toxicological test development. The report and recommen- dations of ECVAM workshop 54 [ J ]. Altern Lab Anim, 2006,34 (1) :49.
  • 8Olivelira E J, Watson DG. Liquid chromatography - mass spec- trometry in the study of the metabolism of drugs and other xenabi- otics[J]. Biomed Chromatogr,2000 ,14( 6 ) :351.
  • 9Koh HL,Yau WP,Ong PS,et al. Current trends in modem phar- maceutical analysis for drug discovery [ J ]. Drug Discov Today. 2003,8(19) :889.
  • 10Korfmaeher WA. Foundation review:Principles and applications of LC - MS in new drug discovery [ J ]. Drug Discov Today, 2005,10(20) :1357.

引证文献3

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部